Top Markets
Coin of the day
Gongwin Biopharm Holdings Co., Ltd. Gongwin Biopharm Holdings Co., Ltd.

Gongwin Biopharm Holdings Co., Ltd.

6617
Ранг среди акций #13752
Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical... Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the development of oncology therapeutics. The company's robust pipeline features several drug candidates, including PTS302, which has successfully concluded Phase III clinical trials for lung cancer. Additionally, PTS100 is currently progressing through Phase II clinical trials for liver cancer, while PTS-02 is being developed to address adenoid cystic carcinoma, and PTS500 targets malignant pleural effusion. Established in 2014, Gongwin Biopharm is headquartered in Taipei, Taiwan.
Цена акции
$3.83
Рыночная капитализация
$464.45M
Изменение (1 день)
-1.63%
Изменение (1 год)
17.17%
Страна
TW
Торговля Gongwin Biopharm Holdings Co., Ltd. (6617)

Категория

История цены акций Gongwin Biopharm Holdings Co., Ltd. (6617)
Наивысшая цена закрытия: $3.43 2026-08-01

Наименьшая цена закрытия: $2.71 2017-02-01
История цены акций Gongwin Biopharm Holdings Co., Ltd. с 2017 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -1.11%
2025 -19.11%
2024 -45.63%
2023 -41.34%
2022 10.61%
2021 7.85%
2020 318.74%
2019 -1.25%
2018 12.21%
2017 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$885.01 28.89%
US
$323.36 10.89%
US
$234.55 57.65%
US
$187.22 0.00%
US
$1.90 -7.01%
AU